Effect Of Topical Nepafenac 0.1% In Prevention Of Macular Edema Post Cataract Surgery In Diabetic Patients At A Tertiary Care Centre In Western India: A Randomized Controlled Trial - NEPATACT

AFMC0 个研究点目标入组 168 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•Diabetic patients with no clinical evidence of diabetic retinopathy who have senile immature cataract scheduled to undergo cataract extraction and posterior chamber Intra-ocular lens implantation.

•1)Anterior segment pathology (corneal opacities, pseudo-exfoliation syndrome, dense cataract interfering with OCT imaging)
•2)Posterior segment pathology, e.g. DR, previous retinal photocoagulation therapy, DME, age-related macular degeneration, retinal vascular diseases or history of uveitis, intra-operative complications including: posterior capsular rupture, vitreous loss or IOL not implanted in the capsular bag.
•3)Postoperative complications: e.g. increased IOP, leaking incision, inflammation or corneal edema;
•4)Patients using concomitant medication such as topical or systemic NSAIDs, steroids which may interfere with the assessment of the study outcome measures, topical prostaglandin analogues;
•5)Hypersensitivity to the NSAIDs;
•6)History of any intraocular surgery and ocular trauma to the same eye.
•7)Patient refusal to participate in study

发起方

AFMC